Share Name Share Symbol Market Type Share ISIN Share Description
Allergan Plc LSE:0Y7T London Ordinary Share IE00BY9D5467 ALLERGAN ORD SHS
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 154.21 0.00 0.00 0.00 0.00 0.00 742 00:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
- - - - 0

Morgan Stanley & Co. LLC Rule 38.5 - ALLERGAN PLC

14/11/2019 11:00am

UK Regulatory (RNS & others)


Allergan (LSE:0Y7T)
Historical Stock Chart

2 Months : From Oct 2019 to Dec 2019

Click Here for more Allergan Charts.

TIDM0Y7T

RNS Number : 4409T

Morgan Stanley & Co. LLC

14 November 2019

FORM 38.5

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 38.5 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2007 (AS AMENDED)

DEALINGS BY CONNECTED EXEMPT MARKET-MAKERS

   1.             KEY INFORMATION 
 
 Name of exempt market-maker            Morgan Stanley & Co. LLC 
 Company dealt in                       ALLERGAN PLC 
                                      -------------------------- 
 Class of relevant security to         US$0.0001 ORDINARY SHARES 
  which the dealings being disclosed 
  relate (Note 1) 
                                      -------------------------- 
 Date of dealing                        13 NOVEMBER 2019 
                                      -------------------------- 
 
   2.             DEALINGS (Note 2) 
   (a)           Purchases and sales 
 
 Total number of relevant   Highest price paid   Lowest price paid (Note 
  secuities accquired        (Note 3)             3) 
 236,782                    182.6700 USD         181.1600 USD 
                           -------------------  ------------------------ 
 
 
 Total number of relevant   Highest price paid   Lowest price paid (Note 
  secuities disposed         (Note 3)             3) 
 226,755                    182.6700 USD         181.1600 USD 
                           -------------------  ------------------------ 
 
   (b)           Derivatives transactions (other than options transactions) 
 
 Product name,   Nature of transaction   Number of relevant   Price per unit 
  e.g. CFD        (Note 4)                securities 
                                          (Note 5) 
 N/A             N/A                     N/A                  N/A 
                ----------------------  -------------------  --------------- 
 
   (c)            Options transactions in respect of existing relevant securities 
   i)           Writing, selling, purchasing or varying 
 
 Product         Writing,        Number           Exercise   Type, e.g    Expiry       Option 
  name, eg        selling,        of securities    Price      American,    Date         money paid/received 
  call option     purchasing,     to which                    European                  per unit 
                  varying         the option                  etc                       (Note 3) 
                  etc             relates 
                                  (Note 5) 
                                                                                       0.1300 
 PUT             PURCHASE        100              175.0000  A             15/11/2019    USD 
                --------------  ---------------  ---------  -----------  -----------  --------------------- 
                                                                                       1.6300 
 CALL            SALE            500              200.0000  A             15/05/2020    USD 
                --------------  ---------------  ---------  -----------  -----------  --------------------- 
 

(ii) Exercising

 
 Product name, eg call   Number of securities   Exercise price per 
  option                                         unit (Note 3) 
 N/A                     N/A                    N/A 
                        ---------------------  ------------------- 
 

3. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

 
 Full Details of any agreement, arrangement or understanding between 
  the person disclosing and any other person relating to the voting 
  rights of any relevant securities under any option referred to 
  on this form or relating to the voting rights or future acquisition 
  or disposal of any relevant securities to which any derivative 
  referred to on this form is referenced. If none, this should 
  be stated. 
 
 
 
 Date of disclosure              14 NOVEMBER 2019 
 Contact Name                   Craig Horsley 
                                ----------------- 
 Telephone Number               +44(141) 245 7736 
                                ----------------- 
 Name of offeree/offeror with   ABBVIE INC. 
  which connected 
                                ----------------- 
Nature of connection (Note 6)   Advisory 
                                ----------------- 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

ISELLFEILDLSLIA

(END) Dow Jones Newswires

November 14, 2019 06:00 ET (11:00 GMT)

1 Year Allergan Chart

1 Year Allergan Chart

1 Month Allergan Chart

1 Month Allergan Chart
Your Recent History
LSE
0Y7T
Allergan
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20191215 20:24:04